Medical Marijuana Use for HIV & AIDS
Can medical marijuana help with HIV and AIDS? Research has focused on appetite loss, weight loss and nerve pain. The FDA has approved one THC drug, dronabinol, for appetite loss with weight loss in people with AIDS, and small trials found short-term relief of HIV nerve pain. No cannabis product is approved for HIV itself.
California was the first state to recognize the medicinal use of cannabis and allowed access to the plant for medical patients back in 1996. By most accounts, the 1996 measure that allowed access to medical marijuana was championed by San Francisco cannabis access advocate Dennis Peron in memory of his partner, Jonathan West. As the story is usually told, West had used cannabis bought on the illicit market for the symptoms of acquired immunodeficiency syndrome (AIDS).
By June 2022, a peer-reviewed study counted 38 states and Washington, DC with medical cannabis laws. Advocates often point to the human immunodeficiency virus (HIV) and AIDS as the illnesses that opened the door to medical marijuana laws in other states. California’s law gave advocates in other states an example to point to.
HIV and AIDS first came to public attention in June 1981, when CDC published its first report on the illness. Doctors in New York and California were seeing rare illnesses such as Kaposi’s sarcoma, a cancer, in young gay men. In 1982, CDC reported the same immune problems in people with hemophilia, and by 1983 cases were also reported among people who inject drugs. By then, CDC had first used the term AIDS, in September 1982.
In 1983 and 1984, researchers identified the virus that causes AIDS, and in 1986 it was officially named HIV. Although they had isolated the virus that caused AIDS, it took many years for scientists to find medicines that could slow the disease, which at the time was usually fatal, and control its symptoms. Before these were discovered, many early AIDS patients turned to cannabis and said smoking it eased their symptoms.
What Are the Stages of HIV and AIDS?
The progression and symptoms can differ from person to person. Without treatment, HIV usually moves through three stages: acute HIV infection, chronic HIV infection and AIDS, HIV.gov explains.
Stage One: Acute Primary Infection
Within 2 to 4 weeks after infection, about two-thirds of people have a flu-like illness. Symptoms of the disease at this stage include:
- Fever
- Body rash
- Sore throat
- Swollen glands
- Chills
- Night sweats
- Muscle pain
- Fatigue
Stage Two: Chronic HIV Infection
After the first stage, people may not feel sick or have any symptoms. Without HIV treatment, people can stay in this stage for 10 or 15 years. However, the virus is still active and replicating and doing damage to the immune system during this stage.
Stage Three: AIDS
By this stage, a patient’s immune system is heavily damaged. At this point, a patient is more susceptible to infections such as bacterial and fungal infections. A healthy immune system would normally fight these infections off, but by this stage the immune system is too damaged to do so.
Symptoms of this stage include:
- Chronic diarrhea
- Fever
- Pneumonia
- Night sweats
- Weight loss
- Mouth and skin lesions
- Regular infections
- Serious illness and disease
A person with HIV is considered to have progressed to AIDS when their CD4 cell count falls below 200 cells per cubic millimeter of blood or they develop one or more opportunistic infections, HIV.gov says. Without treatment, HIV can lead to AIDS; with HIV medicine taken as prescribed, most people with HIV in the U.S. do not develop AIDS and can live long, healthy lives.

Cannabis and HIV/AIDS: What the Research Shows
For people living with HIV, research on cannabis has focused on appetite, weight loss and nerve pain, and the evidence comes from small studies and one approved THC drug.
Here are the HIV/AIDS symptoms cannabis has been studied for.
Nausea and Wasting Syndrome
HIV and AIDS can come with loss of appetite and weight loss, which some medical professionals have called “wasting syndrome.” Wasting was one of the main reasons early advocates pushed for medical marijuana laws. Increased appetite is a commonly reported effect of cannabis, NIDA notes, and in the late 1980s researchers studied THC for weight gain in people with AIDS, NCI says. FDA later approved dronabinol, a synthetic form of THC, for appetite loss with weight loss in people with AIDS.
Marinol (dronabinol) is still prescribed for this use, while smoked cannabis has never been FDA-approved for it.
A 2005 survey of 252 patients found that among those with nausea, people who used marijuana had about 3 times the odds of keeping to their HIV drugs, but it could not show cause and effect, and overall there was no link.
Cannabis was reviewed in 1999 by the Institute of Medicine (IOM), now part of the National Academies. Its report weighed the harm marijuana may do against the relief it may bring to patients, including the prospects for developing cannabinoid drugs.
Peripheral Neuropathy
Along with severe nausea and wasting syndrome, many HIV/AIDS patients suffer from peripheral neuropathy, the same condition that affects many people with type-2 diabetes. It can cause pain, numbness or loss of feeling in the hands and feet. Small trials found a short-term benefit of smoked cannabis for HIV nerve pain, though reviews of neuropathic pain overall are less positive.
A 2005 survey in the Journal of Pain and Symptom Management asked 523 HIV-positive clinic patients about cannabis, and 143 of them (27%) said they used it to manage symptoms.
Of those users, 94% reported less muscle pain and 90% less nerve pain, but these were self-reports, and 47% also reported memory problems.
In a 2009 randomized crossover trial in which 28 people with HIV nerve pain completed both phases, 46% had at least 30% relief on smoked cannabis, versus 18% on placebo.
A 2007 randomized trial in San Francisco had 50 patients smoke cannabis (3.56% THC) or placebo three times a day for 5 days: 52% on cannabis had at least 30% less pain, versus 24% on placebo. In that trial, the first cannabis cigarette cut pain by a median of 72%, compared with 15% for placebo.

Mental Decline
In a 2010 U.S. study of 1,555 adults with HIV, 52% had some thinking impairment, mostly mild. A 2018 Michigan State University study looked at whether THC affects the inflammation thought to drive it.
Researchers think chronic immune activation and inflammation may drive some of this decline in people with HIV. In that study, HIV patients who used cannabis had fewer inflammatory CD16+ monocytes in their blood than non-users; it measured blood markers, not memory or thinking.
Mental Health
HIV.gov lists memory loss, depression and other neurologic disorders among the possible symptoms of AIDS. No study cited here tested cannabis as a treatment for depression or anxiety in people with HIV, though some patients report that it eases their symptoms.
In the 2005 survey, users reported improved depression (86%) and a positive effect of cannabis on anxiety (93%), but self-reports cannot show cause, and CDC links cannabis use with depression.
More clinical studies are needed to show whether cannabis helps symptoms of HIV/AIDS, and how. Since April 28, 2026, marijuana in FDA-approved drugs or under a state medical marijuana license is in federal Schedule III, still a controlled substance; all other marijuana remains in Schedule I. HIV and AIDS are qualifying conditions in Florida. If you live there, talk with your HIV doctor before adding cannabis, keep taking your HIV medicine as prescribed, and ask about drug interactions.
Last updated October 17, 2026 by the Dr. Green Relief Editorial Team.
Medical review
Medically reviewed by Achilles Kalnoky, M.D.
Reviewed on .
He is licensed in Florida as a medical doctor, license ME115088, which you can check on the Florida Department of Health license lookup.
His review covers the medical statements in this post and the sources cited for them.
Sources
- FDA. FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
- MedlinePlus. Dronabinol
- Steuart SR, et al. State Variation in U.S. Medical Cannabis Limits, Restrictions, and Therapeutic Cannabis Dosing. Cannabis. 2023
- de Jong BC, et al. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005
- Institute of Medicine. Marijuana and Medicine: Assessing the Science Base. 1999
- Abrams DI, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007
- Ellis RJ, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009
- Ateş G, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2026
- Woolridge E, et al. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage. 2005
- Heaton RK, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010
- Rizzo MD, et al. HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-inducible protein 10 levels compared with nonusing HIV patients. AIDS. 2018
- CDC. Cannabis and Mental Health
- Federal Register 91 FR 22714 (April 28, 2026). Rescheduling of FDA-Approved Products Containing Marijuana to Schedule III
- Florida Statutes, s. 381.986, Medical use of marijuana
- FDA. What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD
- HIV.gov. A Timeline of HIV and AIDS
- HIV.gov. Acute and Chronic HIV and AIDS
- HIV.gov. What Are HIV and AIDS?
- NIDA. Cannabis (Marijuana)
- National Cancer Institute. Cannabis and Cannabinoids (PDQ), Health Professional Version



